BeyondSpring delays second closings of SEED Therapeutics share sale to H1 2026

BeyondSpring Inc.

Second closings under Preferred Share Purchase Agreement for SEED Therapeutics Series A-1 shares postponed from Dec 2025 to H1 2026.
Three investors (Winning View, FULL TECH, Mapfil) to purchase 3,103,055 shares for ~$13.2M at $4.25/share, now expected H1 2026.
Total deal value for all 8,333,637 shares is $35.4M; no assurance that second closings will not be further delayed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.